Research published in the journal PLoS Biology reveals findings from a group of researchers demonstrating how the genetic anomaly associated with Angelman syndrome interferes with neurological functions essential for memory and learning. Through experiments conducted on mice, the researchers discovered that a new compound could potentially reinstate the healthy functions.

